As of 2025-12-30, the Relative Valuation of 9 Meters Biopharma Inc (NMTR) is (38.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 USD, the upside of 9 Meters Biopharma Inc based on Relative Valuation is -53731.7%.
The range of the Relative Valuation is (37.41) - (38.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 20.5x | 19.9x |
| Forward P/E multiples | 20.0x - 21.7x | 21.5x |
| Fair Price | (37.41) - (38.35) | (38.72) |
| Upside | -51918.1% - -53213.6% | -53731.7% |
| Date | P/E |